Skip to main content
. 2019 Sep 5;8(11):e1659092. doi: 10.1080/2162402X.2019.1659092

Figure 6.

Figure 6.

Co-treatment with the PDK inhibitor, DCA, and anti-PD-L1 antibody suppresses tumor growth in an ID8 ovarian cancer model. (a). Typical presentation of ID8 ovarian cancer tumors in C57BL/6 mice treated with DCA and/or anti-PD-L1 antibody. (b). Scheme of the therapeutic strategy. (c). Overall survival of mice from the four groups. (d). Peritoneal tumors were counted and weighed following euthanization. Each dot represents a single mouse (* P < .05, ** P < .01).